Harris Associates
BIVV

Harris Associates’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Harris Associates’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-53,255
Closed -$2.87M – 140
2017
Q4 		$2.87M Buy
+53,255
New +$2.91M ﹤0.01% 116

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Harris Associates's BIVV Position: Q1 2018 in Review

Harris Associates sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 53,255 shares — an estimated $2.87M sold.

Harris Associates first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $2.87M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Harris Associates reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Harris Associates sold 53,255 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.87M.
  • Harris Associates first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Harris Associates's Bioverativ Inc. Common Stock position peaked at $2.87M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Harris Associates's 13F filing for Q1 2018, filed 15 May 2018.